DE69702862T2 - Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung - Google Patents

Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung

Info

Publication number
DE69702862T2
DE69702862T2 DE69702862T DE69702862T DE69702862T2 DE 69702862 T2 DE69702862 T2 DE 69702862T2 DE 69702862 T DE69702862 T DE 69702862T DE 69702862 T DE69702862 T DE 69702862T DE 69702862 T2 DE69702862 T2 DE 69702862T2
Authority
DE
Germany
Prior art keywords
treat chronic
sulfated polysaccharides
chronic injury
injury
sulfated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69702862T
Other languages
English (en)
Other versions
DE69702862D1 (de
Inventor
William Grady
John Doyle
Laura Sinclair
Paul Houston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Application granted granted Critical
Publication of DE69702862D1 publication Critical patent/DE69702862D1/de
Publication of DE69702862T2 publication Critical patent/DE69702862T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
DE69702862T 1996-09-11 1997-09-10 Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung Expired - Lifetime DE69702862T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9618958A GB2317182B (en) 1996-09-11 1996-09-11 Sulfated polysaccharides and uses thereof in medical treatment
PCT/GB1997/002477 WO1998011141A1 (en) 1996-09-11 1997-09-10 Sulfated polysaccharides and uses thereof in medical treatment

Publications (2)

Publication Number Publication Date
DE69702862D1 DE69702862D1 (de) 2000-09-21
DE69702862T2 true DE69702862T2 (de) 2001-02-22

Family

ID=10799755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69702862T Expired - Lifetime DE69702862T2 (de) 1996-09-11 1997-09-10 Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung

Country Status (14)

Country Link
US (1) US20090227537A1 (de)
EP (1) EP0925310B1 (de)
JP (1) JP2001500184A (de)
KR (1) KR20000036061A (de)
AU (1) AU726555B2 (de)
BR (1) BR9711747A (de)
CA (1) CA2265780C (de)
DE (1) DE69702862T2 (de)
DK (1) DK0925310T3 (de)
ES (1) ES2152107T3 (de)
GB (1) GB2317182B (de)
NO (1) NO991160L (de)
PT (1) PT925310E (de)
WO (1) WO1998011141A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
WO2000056283A1 (en) * 1999-03-24 2000-09-28 The B.F.Goodrich Company Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
DE10050870A1 (de) * 2000-10-11 2002-08-01 Knoell Hans Forschung Ev Biokompatibles Verbundmaterial für medizinische Anwendungen
ES2297516T3 (es) 2003-12-02 2008-05-01 Universiteit Gent Uso de alginato polisulfatado en matrices celulares.
DE102006024748A1 (de) * 2006-05-26 2007-11-29 Paul Hartmann Ag Proteasen-Inhibitor zur Wundbehandlung
DE102007035322B4 (de) 2007-07-25 2011-11-17 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate
EP2281008B1 (de) 2008-04-04 2017-01-04 University of Utah Research Foundation Alkylierte und sulfatierte hyaluronsäure, verfahren zu ihrer herstellung und ihre verwendung
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
EP2688402B1 (de) 2011-03-23 2018-10-24 University of Utah Research Foundation Mittel zur behandlung bzw. prävention von harnwegsentzündungen
US9259455B2 (en) * 2011-04-11 2016-02-16 University Of Massachusetts Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
CN103360499B (zh) * 2012-04-11 2017-02-08 厦门大学 一种纤维素硫酸酯的简便合成工艺
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
US20170182125A1 (en) * 2014-05-23 2017-06-29 Reponex Pharmaceuticals Aps Compositions for promoting the healing of wounds
WO2016012608A1 (en) 2014-07-24 2016-01-28 Reponex Pharmaceuticals Aps Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
US11491199B1 (en) 2021-06-09 2022-11-08 King Abdulaziz University Anticoagulation activity of sulfated carboxymethyl cellulose/Azadirachta indica leaf powder-based biocomposites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1056772A (fr) * 1950-06-23 1954-03-02 Procédé de préparation d'un anticoagulant de synthèse
US3115488A (en) * 1960-02-29 1963-12-24 American Home Prod Alginic acid methyl ester sulfates, preparation and molecular weight fractionation thereof
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
JPS4943937B1 (de) * 1970-12-28 1974-11-25
US3709877A (en) * 1972-03-07 1973-01-09 Johnson & Johnson Process for the sulfation of cellulosic ethers
US3804092A (en) * 1973-01-15 1974-04-16 Johnson & Johnson Water dispersible nonwoven fabric
JPS5152484A (en) * 1974-10-18 1976-05-10 Sumitomo Chemical Co Pururanno ryusanesuteru oyobi sono enruino seizohoho
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
GB2148901A (en) * 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
JPH02178229A (ja) * 1988-12-28 1990-07-11 Fujirebio Inc 抗ウイルス剤
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5997863A (en) * 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes

Also Published As

Publication number Publication date
BR9711747A (pt) 1999-08-24
AU4131597A (en) 1998-04-02
GB9618958D0 (en) 1996-10-23
WO1998011141A1 (en) 1998-03-19
DK0925310T3 (da) 2000-11-20
KR20000036061A (ko) 2000-06-26
CA2265780A1 (en) 1998-03-19
EP0925310A1 (de) 1999-06-30
GB2317182A (en) 1998-03-18
AU726555B2 (en) 2000-11-09
CA2265780C (en) 2006-08-22
GB2317182B (en) 2000-11-01
NO991160D0 (no) 1999-03-10
ES2152107T3 (es) 2001-01-16
PT925310E (pt) 2000-11-30
EP0925310B1 (de) 2000-08-16
JP2001500184A (ja) 2001-01-09
NO991160L (no) 1999-05-10
DE69702862D1 (de) 2000-09-21
US20090227537A1 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
ATE331505T1 (de) Behandlung einer hämoglobinstörung
DE69702862T2 (de) Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69500089T3 (de) Behandlung von Geflügel
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
ATE301617T1 (de) Behandlung von wasser
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
ATE281167T1 (de) Verwendung von makroliden zur behandlung von trockenen augen
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE217518T1 (de) Verwendung mindestens eines in 6-stellung substituierten pyrimidin-3-oxids zur stimulierung von tyrosinase
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69614264D1 (de) Behandlung von aluminiumartikeln zur erhöhung der einbrennhärtbarkeit
ATE410181T1 (de) Verwendung von intereferon gamma zur behandlung von herzhypertrophie
ATE209891T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
ATE270102T1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
ATE190486T1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
DE69525349D1 (de) Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert
DE69717846T2 (de) Behandlungsverfahren von laktamen
DE69709931D1 (de) Bestimmung von wasserbestandteile
DE59808165D1 (de) Verwendung von aminothiazolen zur wund- und hautbehandlung
ATE216885T1 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
DE29510864U1 (de) Hautpflaster zur Fixierung von Drainagen nach operativen Eingriffen
KR970038973U (ko) 수처리용 여과기
DE69232918D1 (de) Verwendung von Carbachol zur Behandlung verringerter willkürlicher Mobilität

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN